Efficacy and Safety of Ingavirin®, Syrup, 30 mg/5 ml, in Children With Influenza and Other Acute Respiratory Viral Infections

NCT05269290 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

240

Enrollment

INDUSTRY

Sponsor class

Conditions

Influenza, Human
Acute Respiratory Infection
Common Cold

Interventions

DRUG: Ingavirin®, syrup, 30 mg/5 ml
DRUG: Placebo

Sponsor

Valenta Pharm JSC